Zebularine Induces Long-Term Survival of Pancreatic Islet Allotransplants in Streptozotocin Treated Diabetic Rats

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Nittby, Henrietta ^a   Ericsson, Peter ^a   Förnvik, Karolina ^a   Strömblad, Susanne ^a   Jansson, Linda ^a   Xue, Zhongtian ^a   Skagerberg, Gunnar ^a   Widegren, Bengt ^a   Sjögren, Hans Olov ^a   Salford, Leif G ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3 DIOXYGENASE 1; INSULIN; UNCLASSIFIED DRUG; ZEBULARINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FISCHER 344 RAT; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; GRAFT SURVIVAL; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CAPSULE; LEWIS RAT; LONG TERM SURVIVAL; MALE; NEPHRECTOMY; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; RAT; SPLEEN; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; CYTIDINE; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GRAFT SURVIVAL; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; RATS; RATS, INBRED F344; RATS, INBRED LEW; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84883150696     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071981     Document Type: Article

References (22)

1. Takemoto S, Terasaki PI, Cecka JM, Cho YW, Gjertson DW, (1992) Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry. N Engl J Med 327: 834-9.
2. Hautz T, Wolfram D, Grahammer J, Starzl R, Krapf C, et al. (2012) Mechanisms and mediators of inflammation: potential models for skin rejection and targeted therapy in vascularized composite allotransplantation. Clin Devel Immunol 2012: 757310.
3. Tudurí E, Kieffer TJ (2011) Reprogramming gut and pancreas endocrine cells to treat diabetes. Diabetes Obes Metab Suppl 1: 53-9.
4. Mudigonda T, Levender MM, O'Neill JL, West CE, Pearce DJ, et al. (2013) Incidence, risk factors, and preventative management of skin cancers in organ transplant recipients: a review of single- and multicenter retrospective studies from 2006 to 2010. http://www.ncbi.nlm.nih.gov/pubmed/2319040839: 345-64.
5. Cheng JC, Matsen CB, Gonzales FA, Ye W, Greer S, et al. (2003) Inhibition of DNA methylation and reactivation of silenced genes by zebularine. J Natl Cancer Inst. 95: 399-409.
6. Flotho C, Claus R, Batz C, Schneider M, Sandrock I, et al. (2009) The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells. Leukemia 6: 1019-28.
7. Xue ZT, Sjögren HO, Salford LG, Widegren B, (2012) An epigenetic mechanism for high, synergistic expression of indoleamine 2,3-dioxygenase 1 (IDO1) by combined treatment with zebularine and IFN-γ: potential therapeutic use in autoimmune diseases. Mol Immunol 51: 101-11.
8. Liu H, Xue ZT, Sjögren HO, Salford LG, Widegren B, (2007) Low dose Zebularine treatment enhances immunogenicity of tumor cells. Cancer Letters 257: 107-115.
9. Belladonna ML, Grohmann U, Guidetti P, Volpi C, Bianchi R, et al. (2006) Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. J Immunol 177: 130-7.
10. Orabona C, Grohmann U, (2011) Indoleamine 2,3-dioxygenase and regulatory function: tryptophan starvation and beyond. Methods Mol Biol 677: 269-80.
11. Hertenstein A, Schumacher T, Litzenburger U, Opitz CA, Falk CS, et al. (2011) Suppression of human CD4+ T cell activation by 3,4-dimethoxycinnamonyl-anthranilic acid (tranilast) is mediated by CXCL9 and CXCL10. Biochem Pharmacol 82: 632-41.
12. Pallotta MT, Orabona C, Volpi C, Vacca C, Belladonna ML, et al. (2011) Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol 12: 870-8.
13. Funeshima-Fuji N, Fujino M, Xie L, Kimura H, Takahara S, et al. (2009) Prolongation of rat major histocompatibility complex-compatible cardiac allograft survival during pregnancy J Heart Lung Transplant. 28: 176-82.
14. Hemmings SJ, Pekush RD, (1994) The impact of type I diabetes on rat liver gamma-glutamyltranspeptidase. Mol Cell Biochem 39: 131-40.
15. Sloan GM, Harrison LC, Underhill LH, Brennan MF, (1981) Inhibition of tumor size by streptozotocin-induced diabetes mellitus. J Surg Res 30: 463-72.
16. He Z, Wang F, Kumagai-Braesch M, Permert J, Holgersson J, (2006) Longterm gene expression and metabolic control exerted by lentivirus transduced pancreatic islets. Xenotransplantation 13: 195-203.
17. Ferrand N, Astesano A, Phan HH, Lelong C, Rosselin G, (1995) Dynamics of pancreatic cell growth and differentiation during diabetes reversion in STZ-treated newborn rats. Am J Physiol 269: C1250-64.
18. Rakieten N, Gordon BS, Beaty A, Cooney DA, Schein PS, et al. (1976) Modification of renal tumorigenic effect of streptozotocin by nicotinamide: spontaneous reversibility of streptozotocin diabetes. Proc Soc Exp Biol Med 151: 356-61.
19. Yoshino G, Matsushita M, Maeda E, Morita M, Nagata K, et al. (1992) Effect of probucol on recovery from streptozotocin diabetes in rats. Horm Metab Res 24: 306-9.
20. Dellê H, Noronha IL, (2010) Induction of indoleamine 2,3-dioxygenase by gene delivery in allogeneic islets prolongs allograft survival. Am J Transplant 10: 1918-24.
21. Li J, Meinhardt A, Roehrich ME, Golshayan D, Dudler J, et al. (2007) Indoleamine 2,3-dioxygenase gene transfer prolongs cardiac allograft survival. Am J Physiol Heart Circ Physiol 293: H3415-23.
22. Bianco NR, Kim SH, Ruffner MA, Robbins PD, (2009) Therapeutic effect of exosomes from indoleamine 2,3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models. Arthritis Rheum 60: 380-9.